CYP46A1 and Huntington disease: Interestingly, most pathways that were predicted to be downregulated (negative z-score) in HD condition (R6/2 non-coding vs WT non-coding comparison), were shown to be upregulated in the CAG-HA-CYP46A1 group (Supplementary Fig. 6C).